These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1205161)

  • 1. [Method of study of factors of the industrial environment in the heterogeneity of O- and Vi-antibodies].
    Zhigunov NF
    Gig Sanit; 1975 Nov; (11):76-9. PubMed ID: 1205161
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
    Chau PY; Tsang RS
    Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of the coons test in studies on immune reaction to oral typhoid vaccination (author's transl)].
    Pershin BB; Lebedev KA; Novikova TA
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):173-80. PubMed ID: 4613132
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolution of the typhoid immunity along one year after intradermal vaccination.
    Dimache G; Croitoru M; Ciordaş C; Velea V
    Arch Roum Pathol Exp Microbiol; 1986; 45(2):147-52. PubMed ID: 3800632
    [No Abstract]   [Full Text] [Related]  

  • 6. Intradermal typhoid vaccination by jet injection.
    Dimache G
    Ann Sclavo Collana Monogr; 1986; 3(1-2):157-63. PubMed ID: 3426873
    [No Abstract]   [Full Text] [Related]  

  • 7. General immunity reactions after oral administration of inactivated typhoid vaccines in man.
    Karolcek J; Drăskovicová M; Georch D
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):143-50. PubMed ID: 4440523
    [No Abstract]   [Full Text] [Related]  

  • 8. A study on the booster effect of typhoid vaccines.
    Varma RN; Boparai MA; Murthy RG
    Indian J Public Health; 1973; 17(3):91-100. PubMed ID: 4802379
    [No Abstract]   [Full Text] [Related]  

  • 9. [Animal and human studies on oral vaccination against typhoid and paratyphoid fever (author's transl)].
    Meshalova AN; Kurlova VI; Yanisker GY; Lavrovskaya VM; Blant ME; Negina YP
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):167-71. PubMed ID: 4216250
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics of Vi-antibody formation in typhoid fever and chronic typhoid fever bacterial carriers].
    Karmanov MI
    Sov Med; 1973 May; 36(5):149-50. PubMed ID: 4768336
    [No Abstract]   [Full Text] [Related]  

  • 11. Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.
    Zhou WZ; Koo HW; Wang XY; Zhang J; Park JK; Zhu F; Deen J; Acosta CJ; Chen Y; Wang H; Galindo CM; Ochiai L; Park T; von Seidlein L; Xu ZY; Clemens JD
    Pediatr Infect Dis J; 2007 Nov; 26(11):1001-5. PubMed ID: 17984806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses to heat-killed, phenol preserved parenteral typhoid vaccine.
    Chaicumpa W; Wechsathanarak Y; Tantivanich S; Plueksawan W
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):371-6. PubMed ID: 4095599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typhim Vi vaccine against typhoid fever: a clinical trial in Kenya.
    Mirza NB; Wamola IA; Estambale BA; Mbithi E; Poillet M
    East Afr Med J; 1995 Mar; 72(3):162-4. PubMed ID: 7796767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and systemic immunity after typhoid vaccines.
    Tagliabue A; Villa L; Boraschi D; Nencioni L
    Ann Sclavo Collana Monogr; 1986; 3(1-2):31-9. PubMed ID: 3322341
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monoclonal antibodies against the lipopolysaccharide of Salmonella typhi 9,12,VI:d. Analysis of passive protection in a mouse model of typhoid fever].
    Paniagua J; Isibasi A; Pelayo R; Ortiz V; Muy M; González C; García JA; Islas S
    Arch Invest Med (Mex); 1989; 20(4):315-20. PubMed ID: 2488771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the production of IgG, IgA- and IgM-antibodies to somatic antigens of Salmonella typhi in humans.
    Chernokhvostova E; Luxemburg KI; Starshinova V; Andreeva N; German G
    Clin Exp Immunol; 1969 Apr; 4(4):407-21. PubMed ID: 4182404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typhoid fever survey in two localities in Vietnam.
    Prokopec J; Müllerová H; Serý V; Dinh Thi Canh ; Radkovský J
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(1):9-16. PubMed ID: 1880411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine.
    Yang HH; Kilgore PE; Yang LH; Park JK; Pan YF; Kim Y; Lee YJ; Xu ZY; Clemens JD
    J Infect Dis; 2001 Jun; 183(12):1775-80. PubMed ID: 11372030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
    Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
    J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [General immune reactions in man following oral administration of acetone-inactivated typhoid vaccines. II].
    Karolcek J; Draskovicová M; Greorch D; Mikulková V; Luzová D
    Zentralbl Bakteriol Orig; 1969; 211(4):502-10. PubMed ID: 4916992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.